DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Rosenblum D, Gutkin A, Kedmi R. et al.
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
Sci Adv 2020;
6 (47) eabc9450
We do not assume any responsibility for the contents of the web pages of other providers.